Nat-Imatinib 400 mg

Imatinib 400 mg tablets are a prescription medication used to treat certain types of cancer. This oral tablet is manufactured by Natco Pharma (Canada) Inc. and is available in a pack size of 30.

Imatinib is primarily used in the treatment of various types of cancer, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). It works by targeting specific proteins in cancer cells to inhibit their growth. Imatinib 400 mg tablets are often prescribed as part of a broader treatment plan determined by a healthcare provider.

Common effects of Imatinib may include nausea, vomiting, muscle cramps, and fatigue. Some users may also experience swelling, skin rashes, or changes in blood counts. These effects can vary widely among individuals and are not exhaustive.

Imatinib should be handled with care, following the instructions provided by a healthcare professional. It is important to store the medication properly and to avoid missing doses. Regular monitoring may be required to assess the medication's impact on the body.

Imatinib may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect the efficacy of Imatinib.